City of Hope · 6 hours ago
Postdoctoral Fellow - Hematologic Malignancies
City of Hope is at the forefront of groundbreaking research in the fight against cancer and other life-threatening illnesses. They are seeking a Postdoctoral Fellow to conduct basic and translational research on hematologic malignancies, focusing on the genetic and molecular mechanisms driving disease progression.
AssociationEducationHealth Care
Responsibilities
Lead independent and collaborative projects investigating the molecular and cellular basis of hematologic malignancies
Work with mouse models, human tumor samples, and high-throughput technologies (e.g., next-generation sequencing, flow cytometry, and immunohistochemistry)
Analyze genomic, transcriptomic, and phenotypic data to identify mechanisms of cancer progression and therapeutic resistance
Collaborate with a multidisciplinary team of scientists, pathologists, and clinicians
Contribute to the preparation of high-impact publications, grant proposals, and scientific presentations
Receive mentorship in experimental design, translational research, and career development
Qualification
Required
A PhD, MD or MD/PhD in molecular biology, cancer genetics, cancer biology, pathology, immunology, or a related biomedical field
Familiarity with flow cytometry, RNA/DNA analysis, immunohistochemistry, or genomic technologies
Demonstrated productivity through peer-reviewed publications
Preferred
Strong research background in genetic engineered mouse modeling, molecular and cellular biology; experience with hematologic malignancies or cancer genomics is preferred
Benefits
Comprehensive Benefits
Company
City of Hope
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.
Funding
Current Stage
Late StageTotal Funding
$10.3MKey Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M
Leadership Team
Recent News
Genetic Engineering News
2026-01-11
2026-01-09
Company data provided by crunchbase